Pilot, Neoadjuvant Gemcitabine and Abraxane Chemotherapy Followed by Surgery, Adenocarcinoma of the Pancreas
Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This study is for adult patients with adenocarcinoma of the pancreas. The purpose of this
research study is to evaluate the safety and effectiveness of the drugs Gemcitabine and
Abraxane in the treatment of adenocarcinoma of the pancreas before surgery. Subjects will
have screening tests to determine if he or she is eligible to participate in this study.